Proniras Corp. launches in Seattle, scores $89.5 million contract to develop new seizure drug by Clare McGrane on April 27, 2018April 27, 2018 at 6:00 am Accelerator Life Science Partners, a Seattle-based life sciences investment fund and umbrella company, unveiled its newest company with a bang Friday. Proniras Corporation was created to develop the seizure drug tezampanel,… Read More